Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-07 06:42:34 - browse：655

Illustration of three connected puzzle pieces, with a woman standing near the missing/empty puzzle piece space. -- first opinion coverage from STAT — Adobe

Women have always been underrepresented in medical research. A new study reveals that not much has changed, especially when it comes to tests of cardiovascular devices.

In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022. The percentages varied between devices: Women made up 46% of participants in orthopedic trials, but 29% in cardiovascular studies.

The issue isn’t new. The government has made some strides in correcting earlier missteps, like the Food and Drug Administration telling researchers in 1977 to exclude women of reproductive potential from early clinical trials. But stakeholders think agencies like the FDA could do more to incentivize the enrollment of women.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Food makers tried to stack nutrition panel with preferred experts

hotspot

entertainment

WSS

Group behind ProMed defends move to subscription

'Null' research findings aren't empty of meaning. Let's publish them

Pharma showers House GOP doctor with campaign cash

Food makers to regulators: Ultra

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

WATCH: Why do bright lights make us see spots?

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Continuity nursing helped my family in our darkest PICU moments

IRA could hurt research into orphan drugs for rare diseases

Cancer drug shortages should be causing more outrage

Flint parents haunted by uncertainty, fears of lead poisoning

Drug repurposing or repositioning? The language matters

Food makers tried to stack nutrition panel with preferred experts

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

FDA approves Sage Therapeutics’ rapid

Bright Health sells Medicare Advantage business to Molina

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

explore

Will the IRA bring competition to the biologics market?

Regeneron agrees to White House price limits on anti

Biotech startup Celsius cuts 75% of staff ahead of first trial start

FDA scientists endorse Pfizer/BioNTech Covid

Popular nasal decongestant doesn't actually relieve congestion

Regeneron agrees to White House price limits on anti

hotspot

entertainment

entertainment

focus